Connect with others who understand.

sign up log in
About MyMyelomaTeam

Watch on Demand: Managing and Treating Leukemia and Other Blood Cancers

Updated on September 27, 2021
Article written by
Torrey Kim

“Fatigue can be very difficult to fix — but having said that, one of the things we do when we're assessing folks with blood cancer is try to see if there are, in fact, reversible causes of fatigue.”

Dr. Matt Kalaycio shared this important insight during MyMyelomaTeam’s latest Q&A session, when members of the myeloma community had a chance to learn more about managing and treating blood cancers.

Dr. Kalaycio joined MyMyelomaTeam’s Heather Lapidus Glassner to answer questions on how to manage fatigue, whether cardiac conditions can occur alongside blood cancers, and how someone would know whether they’re a candidate for a stem cell transplant.

Check out the video for a few more topics Dr. Kalaycio discussed during the Q&A session:

  • Whether people with blood cancer should get vaccinated against COVID-19
  • How to handle mental health symptoms when living with blood cancer
  • Tips for talking to your oncologist via telehealth

Watch the video to see the entire one-hour event, and register to be notified about upcoming Q&A sessions on MyMyelomaTeam.

Disclaimer: The information, including but not limited to, information from presenters, text, graphics, images, and other material shared during this event is for informational purposes only. The information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you heard during this event.

Speakers:

Dr. Matt Kalaycio is a board-certified hematologist and a professor in the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. Dr. Kalaycio sits on the board of directors for the National Comprehensive Cancer Network (NCCN). His clinical interests include leukemia and hematopoietic cell transplantation, and he has published more than 200 research articles in scientific journals. Dr. Kalaycio is a former chairman of the department of hematology and medical oncology at the Taussig Cancer Institute at Cleveland Clinic, and he previously served as editor-in-chief of Hematology News. Dr. Kalaycio is a fellow of the American College of Physicians.

Heather Lapidus Glassner has over two decades of experience in market research. She has been with MyHealthTeams for six years, conducting social listening and quantitative survey research. Her focus is to raise awareness of life with chronic conditions, including leukemia, multiple sclerosis, lupus, Parkinson’s disease, COPD, Crohn’s disease and ulcerative colitis, migraine, and psoriasis. Heather's work has been presented at the Consortium of Multiple Sclerosis Centers and the International Congress on Systemic Lupus Erythematosus.

Torrey Kim is the managing editor at MyHealthTeams and has over a decade of experience writing about medical conditions. Learn more about her here.

A MyMyelomaTeam Member said:

That is within normal range. 30.8 is a good number.

posted about 1 month ago

hug (1)

Recent articles

Multiple myeloma is a cancer of plasma cells. This disease can present a variety of challenges,...

Living With Multiple Myeloma

Multiple myeloma is a cancer of plasma cells. This disease can present a variety of challenges,...
Recent medical advances have helped improve the survival rates and quality of life for people...

Dental Issues and Multiple Myeloma

Recent medical advances have helped improve the survival rates and quality of life for people...
People with multiple myeloma currently may be eligible for a third dose of the Pfizer and Moderna...

COVID-19 Vaccine Boosters and Additional Doses for People With Myeloma: Current Guidelines

People with multiple myeloma currently may be eligible for a third dose of the Pfizer and Moderna...
During the COVID-19 pandemic, MyMyelomaTeam will provide summaries and links to articles of...

COVID-19 and Myeloma Essential Updates

During the COVID-19 pandemic, MyMyelomaTeam will provide summaries and links to articles of...
Back pain is a common and challenging symptom of myeloma and is often one of the first symptoms...

Back Pain and Myeloma

Back pain is a common and challenging symptom of myeloma and is often one of the first symptoms...
Plasmacytoma and multiple myeloma are similar cancers of the plasma cells in the blood or bone...

Plasmacytoma: Is It Different From Myeloma?

Plasmacytoma and multiple myeloma are similar cancers of the plasma cells in the blood or bone...
I have developed a nine-point plan that I follow faithfully. This plan has enabled me to feel...

My Perspective: Living Well With Cancer

I have developed a nine-point plan that I follow faithfully. This plan has enabled me to feel...
Multiple myeloma is a type of cancer that happens when lymphocytes (white blood cells) called...

Itchy Skin and Multiple Myeloma

Multiple myeloma is a type of cancer that happens when lymphocytes (white blood cells) called...
Staging in myeloma is used to predict disease progression and survival, and it helps inform...

Understanding the Stages of Multiple Myeloma: Q&A With Dr. Mohan

Staging in myeloma is used to predict disease progression and survival, and it helps inform...
Myeloma refers to a type of cancer that affects the plasma cells. A type of white blood cell,...

Stage 3 Multiple Myeloma: Outlook and Survival

Myeloma refers to a type of cancer that affects the plasma cells. A type of white blood cell,...
MyMyelomaTeam My myeloma Team

Two Ways to Get Started with MyMyelomaTeam

Become a Member

Connect with others who are living with myeloma. Get members only access to emotional support, advice, treatment insights, and more.

sign up

Become a Subscriber

Get the latest articles about myeloma sent to your inbox.

Not now, thanks

Privacy policy
MyMyelomaTeam My myeloma Team

Thank you for signing up.

close